Harmonizing the COVID-19 sample biobanks: Barriers and opportunities for standards, best practices and networks

Li, 2020, Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia, N. Engl. J. Med., 382, 1199, 10.1056/NEJMoa2001316 Henderson, 2020, The responses of biobanks to COVID-19, Biopreserv Biobank., 18, 483, 10.1089/bio.2020.29074.mkh Medina, 2022, Construction and application of biobanks for infectious diseases: focus on SARS-CoV-2, Innov. Digital Health Diagnost. Biomarkers, 2, 40, 10.36401/IDDB-21-06 Campbell, 2018, revision of the ISBER Best Practices: Summary of changes and the editorial team’s development process, Biopreserv. Biobank., 16, 3, 10.1089/bio.2018.0001 Organization for Economic Co-operation and Development (OECD), 2006 Mendy, 2017 Furuta, 2018, Standardization and innovation in paving a path to a better future: An update of activities in ISO/TC276/WG2 Biobanks and Bioresources, Biopreserv. Biobank., 16, 23, 10.1089/bio.2017.0117 Simeon-Dubach, 2018, New standards and updated best practices will give modern biobanking a boost in professionalism, Biopreserv. Biobank., 16, 1, 10.1089/bio.2017.0126 Colledge, 2013, A review of the barriers to sharing in biobanking, Biopreserv. Biobank., 11, 339, 10.1089/bio.2013.0039 World Health Organization, International Health Regulations, 3rd ed. Geneva: WHO Press, 2008. https://www.who.int/publications/i/item/9789241580496, 2005 (accessed 21 March 2022). World Health Organization, Pandemic influenza preparedness framework for the sharing of influenza viruses and access to vaccines and other benefits. https://apps.who.int/iris/bitstream/handle/10665/44796/9789241503082_eng.pdf, 2011 (accessed 21 March 2022). Secretariat of the Convention on Biological Diversity, The Nagoya protocol on access to genetic resources and the fair and equitable sharing of benefits arising from their utilization (ABS) to the convention on biological diversity. https://www.cbd.int/abs/doc/protocol/nagoya-protocol-en.pdf, 2011 (accessed 21 March 2022). Rourke, 2022, Sovereignty, sanctions, and data sharing under international law, Science, 375, 724, 10.1126/science.abn5400 Lu, 2020, Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding, Lancet, 395, 565, 10.1016/S0140-6736(20)30251-8 Sett, 2021, Access and benefit-sharing by the European Virus Archive in response to COVID-19, Lancet Microbe., 3, e316, 10.1016/S2666-5247(21)00211-1 Hofman, 2020, Challenges and issues surrounding the use for translational research of human samples obtained during the COVID-19 pandemic from lung cancer patients, Transl. Lung Cancer Res., 9, 1543, 10.21037/tlcr-20-594 Zika, 2011, A European survey on biobanks: trends and issues, Public Health Genom., 14, 96, 10.1159/000296278 Ta, 1897, Biosafety and biohazards: understanding biosafety levels and meeting safety requirements of a biobank, Methods Mol. Biol., 2019, 213 Asplund, 2019, Contaminating viral sequences in high-throughput sequencing viromics: a linkage study of 700 sequencing libraries, Clin. Microbiol. Infect., 25, 1277, 10.1016/j.cmi.2019.04.028 Vandenberg, 2021, Considerations for diagnostic COVID-19 tests, Nat. Rev. Microbiol., 19, 171, 10.1038/s41579-020-00461-z Sagan, 2020, World Health Organization, COVID-19 and health systems resilience: lessons going forwards, Eurohealth, 26, 20 Kozlakidis, 2020, Clinical microbiology in low resource settings, Front. Med., 7, 258, 10.3389/fmed.2020.00258